Research Article
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma
Table 2
Demographics of healthy controls and patient with CHB, LC, and HCC.
| | Features | HC | CHB | LC | HCC |
| | Number | 93 | 27 | 49 | 129 | | Age | 55 (21-79) | 52 (33-71) | 58 (35-87) | 59 (23-88) | | Male/female | 69/24 | 21/6 | 32/17 | 111/18 | | AFP (ng/mL) | 2.22 (0.68-6.70) | 2.62 (0.95-569.0) | 4.03 (0.61-759.0) | 38.50 (0.61-22484.0) | | GGT (U/L) | 16 (7-59) | 36 (8-209) | 64.5 (9-759) | 80 (13-2000) | | ALT (U/L) | 18 (9-46) | 28 (12-2112) | 29.5 (8-1688) | 37 (7-1198) | | AST (U/L) | 20 (14-38) | 25 (18-1856) | 54 (16-639) | 41 (17-1474) | | TP (g/L) | 73.7 (65.1-81.8) | 71.1 (59.1-77) | 63.7 (48.6-78.2) | 68.6 (43.4-84.8) | | ALB (g/L) | 45.5 (40.5-50.5) | 45.1 (28-49.2) | 28.8 (22.5-28.6) | 40.1 (21.4-48.9) |
|
|
HC: healthy control; HCC: hepatocellular carcinoma; CHB: chronic hepatitis B; LC: liver cirrhosis; AFP: alpha fetoprotein; GGT: gamma-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartic transaminase; TP: total protein; ALB: albumin.
|
